A rare inherited mutation in the Epidermal Growth Factor Receptor (EGFR) gene is associated with a 25-fold increased risk of lung cancer, according to a study by investigators at Dana-Farber Cancer ...

The gene is found predominantly in Southern Appalachia and may be one of the most powerful cancer-risk mutations ever found.

A rare genetic mutation could help to explain why some people who don’t smoke still develop lung cancer.

New phase 3 data add to a growing number of EGFR-directed first-line options for advanced NSCLC with EGFR exon 20 insertions.

A genetic mutation that raises lung cancer risk was much more common among those born in Southeastern states than elsewhere in the U.S.

A rare inherited germline mutation was found to increase risk for lung cancer by 25 times, while smoking only increased risk by 4 times.

Akeso has received clearance from the Center for Drug Evaluation (CDE) under China's National Medical Products Administration (NMPA) to begin a Phase I trial of AK158D1, an investigational bispecific ...

The eGFR line on your blood panel is your main kidney score, and most people never learn to read it.

Adding zipalertinib to platinum-pemetrexed chemotherapy significantly improved progression-free survival in patients ...